絞り込み

16758

広告

「"ann rheum dis"[Journal]」の検索結果

15361件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era.

Response to: 'Reactive arthritis, a missing link: cmment on the recent article from Sepriano ' by Zeidler and Hudson.

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.

Laboratory investigation results influence Physician's lobal ssessment (PGA) of disease activity in SLE.

Response to: 'Glucocorticoid withdrawal in lupus: to do or not to do?' by Acharya.

Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial.

Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach?

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.

Subtype-specific gout susceptibility loci and enrichment of selection pressure on and identified by subtype genome-wide meta-analyses of clinically defined gout patients.

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.

Terminology and definition of 'antinuclear antibodies': history and current debate.

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.

Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.

Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study.

Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります